Company · CIK 1851194

# Ventyx Biosciences, Inc.

| CIK | [1851194](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001851194) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-11-18 |

## Offerings

 5 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-278584 | Shelf Effective | 2024-04-09 | 2026-03-06 | 3 |
| 333-283076 | Shelf Effective | 2024-11-07 | 2026-03-06 | 3 |
| 333-268909 | Shelf Effective | 2022-12-20 | 2024-04-26 | 2 |
| 333-267626 | Registered company Effective | 2022-09-27 | 2022-12-22 | 3 |
| 333-259891 | IPO Final prospectus | 2021-09-29 | 2021-10-21 | 5 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999526000741/9999999995-26-000741-index.htm) Declared effective | 333-283076 | 9999999995-26-000741 |
| 2026-03-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999526000740/9999999995-26-000740-index.htm) Declared effective | 333-278584 | 9999999995-26-000740 |
| 2024-11-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999524003504/9999999995-24-003504-index.htm) Declared effective | 333-283076 | 9999999995-24-003504 |
| 2024-11-07 | [S-3](https://www.sec.gov/Archives/edgar/data/1851194/000119312524253293/0001193125-24-253293-index.htm) Shelf registered | 333-283076 | 0001193125-24-253293 |
| 2024-04-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999524001185/9999999995-24-001185-index.htm) Declared effective | 333-278584 | 9999999995-24-001185 |
| 2024-04-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999524001142/9999999995-24-001142-index.htm) Declared effective | 333-268909 | 9999999995-24-001142 |
| 2024-04-09 | [S-3](https://www.sec.gov/Archives/edgar/data/1851194/000119312524090959/0001193125-24-090959-index.htm) Shelf registered | 333-278584 | 0001193125-24-090959 |
| 2022-12-22 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999522003620/9999999995-22-003620-index.htm) Declared effective | 333-267626 | 9999999995-22-003620 |
| 2022-12-20 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1851194/000119312522309145/0001193125-22-309145-index.htm) Shelf registered | 333-268909 | 0001193125-22-309145 |
| 2022-10-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999522002920/9999999995-22-002920-index.htm) Declared effective | 333-267626 | 9999999995-22-002920 |
| 2022-09-27 | [S-1](https://www.sec.gov/Archives/edgar/data/1851194/000119312522251475/0001193125-22-251475-index.htm) Registration filed | 333-267626 | 0001193125-22-251475 |
| 2021-10-21 | [424B4](https://www.sec.gov/Archives/edgar/data/1851194/000119312521304165/0001193125-21-304165-index.htm) Final prospectus | 333-259891 | 0001193125-21-304165 |
| 2021-10-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1851194/999999999521003965/9999999995-21-003965-index.htm) Declared effective | 333-259891 | 9999999995-21-003965 |
| 2021-10-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1851194/000119312521299315/0001193125-21-299315-index.htm) Amendment | 333-259891 | 0001193125-21-299315 |
| 2021-10-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1851194/000119312521298518/0001193125-21-298518-index.htm) Amendment | 333-259891 | 0001193125-21-298518 |
| 2021-09-29 | [S-1](https://www.sec.gov/Archives/edgar/data/1851194/000156459021049504/0001564590-21-049504-index.htm) Registration filed | 333-259891 | 0001564590-21-049504 |
| 2021-08-20 | [DRS](https://www.sec.gov/Archives/edgar/data/1851194/000095012321011766/0000950123-21-011766-index.htm) Draft made public | 377-05394 | 0000950123-21-011766 |

[All filings of this company](https://equitycapital.markets/filings?cik=1851194) · [CSV](https://equitycapital.markets/filings.csv?cik=1851194)

---
Source page: https://equitycapital.markets/company/1851194 · Data: U.S. SEC EDGAR · CC BY 4.0